Contact us

Home » Disease Areas » Gastrointestinal » Streptococcus portfolio

Streptococcus portfolio

Streptococcal infections range from neonatal disease and invasive sepsis to pharyngitis and zoonotic infections. Accurate serogrouping and serotyping support diagnosis, surveillance, and vaccine research. At SSI Diagnostica Group, we provide reference materials and high‑quality antisera used by laboratories and vaccine developers worldwide. 

Product scope 

  • Group B streptococcus (GBS, also known as Streptococcus agalactiae): Type antisera Ia–IX for Neufeld (capsular reaction) and Lancefield testing and ImmuLex™ Strep‑B latex kit for rapid agglutination. 
  • Streptococcus suis: Type antisera (selected serotypes) for Neufeld (capsular reaction) and Lancefield testing. 

Methods and use 

Our portfolio supports established serological methods: 

  • Lancefield test (precipitin in capillary tube) for group confirmation and serotyping. 
  • Latex agglutination (ImmuLex™) for rapid results. 
  • Neufeld (capsular reaction / Quellung) for capsule‑expressing streptococci (e.g., S. suis and Group B Streptococcus). 

If you have any questions, comments, or collaboration inquiries, you are very welcome to reach out.

Please fill in the form and we will get back to you as soon as possible.